Press Releases News Category CompanyFinancialGeneralProductScience Year None202320222021 Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Preliminary Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc. Sep 19, 2022 Read More Aesther Healthcare Acquisition Corp. Announces Intention to Extend Period to Consummate Business Combination Sep 12, 2022 Read More Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce $75 Million Common Stock Purchase Transaction with White Lion Capital Sep 08, 2022 Read More Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%, Announced by Ocean Biomedical, Inc. and Aesther Healthcare A Sep 06, 2022 Read More Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ Aug 31, 2022 Read More Ocean Biomedical, Inc. Files Registration Statement For Proposed Initial Public Offering Jun 10, 2021 Read More Ocean Biomedical, Inc. Announces Confidential Submission of Draft Registration Statement for Proposed Public Listing Mar 25, 2021 Read More First page « Previous page ‹ Page 1 Page 2 Page 3 Page 4 Page 5 Current page 6 Displaying 51 - 57 of 57
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Preliminary Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc. Sep 19, 2022 Read More
Aesther Healthcare Acquisition Corp. Announces Intention to Extend Period to Consummate Business Combination Sep 12, 2022 Read More
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce $75 Million Common Stock Purchase Transaction with White Lion Capital Sep 08, 2022 Read More
Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%, Announced by Ocean Biomedical, Inc. and Aesther Healthcare A Sep 06, 2022 Read More
Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ Aug 31, 2022 Read More
Ocean Biomedical, Inc. Files Registration Statement For Proposed Initial Public Offering Jun 10, 2021 Read More
Ocean Biomedical, Inc. Announces Confidential Submission of Draft Registration Statement for Proposed Public Listing Mar 25, 2021 Read More
